Delivery Order SPE2DB22D1106-SPE2DB22FDLU2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,648.00 firm fixed price delivery order is for the supply of XEOMIN 200 UNIT VIALS, a specialty medication. The award has an ultimate completion date of April 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which maintains several Indefinite Delivery Contracts (IDCs)...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,057.69 firm fixed-price delivery order is for the supply of 4,565 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $4,103.68 for the supply of 4,558,237,997 units of XEOMIN 200 unit vials. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,508.70 delivery order is for the supply of XEOMIN 100 unit vials, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award, valued at $1,572.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award, valued at $13,559.00, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order for the provision of 4,566,773,316 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,793.70 firm fixed-price delivery order is for the supply of 4,568,239,300 units of XEOMIN 100 unit vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $8,550.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564795627 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XEOMIN 200 unit vials. The firm-fixed-price delivery order, valued at $4,193.92, has an ultimate completion date of August 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The $31,454.40 firm fixed price delivery order is for the supply of 4,564,077,143 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This single...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB22FDLU2Delivery Order
This federal contract award, valued at $86,177.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order for the supply of 4,559,517,536 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has an Ultimate Completion Date of September 12, 2022 and was awarded on August 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00, to provide a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.2k | 8/19/22 |